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Integrated regulatory models for inference of
subtype-specific susceptibilities in glioblastoma
Yunpeng Liu1,2,3, Ning Shi4, Aviv Regev1,2,3, Shan He4 & Michael T Hemann1,2,3,*
Abstract
Glioblastoma multiforme (GBM) is a highly malignant form of
cancer that lacks effective treatment options or well-defined
strategies for personalized cancer therapy. The disease has been
stratified into distinct molecular subtypes; however, the underly-
ing regulatory circuitry that gives rise to such heterogeneity and
its implications for therapy remain unclear. We developed a modu-
lar computational pipeline, Integrative Modeling of Transcription
Regulatory Interactions for Systematic Inference of Susceptibility
in Cancer (inTRINSiC), to dissect subtype-specific regulatory
programs and predict genetic dependencies in individual patient
tumors. Using a multilayer network consisting of 518 transcription
factors (TFs), 10,733 target genes, and a signaling layer of 3,132
proteins, we were able to accurately identify differential regula-
tory activity of TFs that shape subtype-specific expression land-
scapes. Our models also allowed inference of mechanisms for
altered TF behavior in different GBM subtypes. Most importantly,
we were able to use the multilayer models to perform an in
silico perturbation analysis to infer differential genetic vulnerabili-
ties across GBM subtypes and pinpoint the MYB family member
MYBL2 as a drug target specific for the Proneural subtype.
Keywords cell state plasticity; gene essentiality inference; glioblastoma
multiforme; subtype-specific gene regulation; transcription regulatory
networks
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Introduction
Glioblastoma multiforme (GBM) is the most common type of
primary brain tumors, accounting for 80% of primary malignancies
in the brain (Hanif et al, 2017). Despite being a rare disease,
affecting less than 10 in 100,000 adults globally per year (Hanif
et al, 2017), GBM remains one of the most clinically challenging
types of tumor, with a dismal median survival of ~ 15 months after
diagnosis (Koshy & Mccarthy, 2014). Current treatment options
include surgery, radiotherapy, and chemotherapy (temozolomide),
which have been shown to extend patient survival but are not cura-
tive (Weller et al, 2005). Targeted therapies against growth factor
receptors, PI3K/AKT/mTOR and MAPK pathways as well as cell
cycle control are either currently under clinical trials or have shown
little or no efficacy (Li et al, 2016; Zhao et al, 2017). Immunothera-
pies, including engineered chimeric antigen receptor T cells (CAR-T
cells) against tumor antigens (IL-13Ra2, HER2, EGFRvIII etc.), have
shown sporadic successes in animal models (Krenciute et al, 2017)
and recent clinical trials (Rourke et al, 2017; Ahmed et al, 2020),
yet factors including the highly immunosuppressive microenviron-
ment in the brain and target antigen loss have posed significant
obstacles to favorable responses.
Key therapeutic challenges in targeting GBM stem from high
levels of heterogeneity within and across tumors, as well as the
anatomically protected location of the tumors. In a pioneering effort
to understand GBM heterogeneity, Verhaak et al (2010) performed
multi-omics profiling of GBM tumors that uncovered four major
molecular subtypes based on transcriptome signatures, named Clas-
sical, Neural, Proneural, and Mesenchymal. These four subtypes,
which have recently been revised to three due to the Neural subtype
likely arising from normal neuronal tissues in tumor margins (Wang
et al, 2017), display distinct mutational landscapes as well as
responses to radiotherapy. Interestingly, recent work on mapping
the clonal organization of patient tumors (Sottoriva et al, 2013) as
well as single-cell transcriptome profiling of GBM tumor samples
have shown that expression signatures of the Classical, Proneural,
and Mesenchymal subtypes are manifested at the single-cell level
(Patel et al, 2014; Wang et al, 2017), suggesting that individual
tumors fall into each of the three subtypes due to the fact that the
majority of tumor cells within the tumor exhibit the corresponding
subtype’s signature. More recent single-cell studies have revealed
additional layers of intra-tumoral heterogeneity due to the co-exis-
tence of immune cells (Darmanis et al, 2017) as well as plasticity of
transcriptional programs within the same tumor (Neftel et al, 2019).
These observations imply that a key route to dissecting GBM intra-
and intertumoral heterogeneity is understanding the transcription
regulatory networks that give rise to the different molecular
subtypes and cell states. Despite the highly challenging nature of
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such a task, a reasonable starting point is to infer the regulatory
code of subtype-/cell state-specific expression programs. Pinpoint-
ing the transcription factors that are responsible for shaping distinct
GBM transcriptional subtypes would provide a mechanistic view of
the source of heterogeneity and, more importantly, allow systematic
inference of susceptibilities in each subtype of GBM that would in
turn facilitate the design of targeted therapy.
Several computational models have been proposed to under-
stand global transcription regulation in mammalian cells so far.
These models infer genome-wide regulatory links between TFs and
target genes primarily using one or more of the following strate-
gies: (i) expression association methods, (ii) analysis of physical
binding of TF to promoters and enhancers, and (iii) regression
models. Association between the expression of TFs and target
genes are quantified by either co-expression metrics (Stuart et al,
2003; Langfelder & Horvath, 2007; Gaiteri et al, 2014; Liu et al,
2014; Aibar et al, 2017) or mutual information (Margolin et al,
2006; Lachmann et al, 2016) to infer potential regulatory relation-
ships. However, these methods do not allow direct inference of
causal relationships in transcription regulation, and association-
based links usually need to be filtered based on additional
evidence. Moreover, the parameters in these models do not contain
direct information on both the magnitude and directionality of TF
regulation of a given target, despite the fact that some of them can
be interpreted as magnitude in a probabilistic fashion [e.g.,
ARACNe (Margolin et al, 2006; Lachmann et al, 2016)] or using
rank-based scores [e.g., GENIE3 (Huynh-Thu et al, 2010)]. In TF
physical binding-based models, ChIP-seq or chromatin accessibility
datasets are used in combination with TF motif databases to deter-
mine regulatory links (Gerstein et al, 2012; Neph et al, 2012;
Marbach et al, 2016). However, these methods also fail to explic-
itly model the magnitude of regulation. Linear regression models
of transcription regulation assign coefficients that describe both the
directionality in which and the relative extent to which each TF
regulates each target gene (Setty et al, 2012; Li et al, 2014; Pearl
et al, 2019). However, these models do not allow biologically
meaningful interpretations of the inferred regulatory relationships,
as gene expression regulation acts in a nonlinear fashion. Plaisier
et al (2016) proposed an integrated genomic and transcriptomic
model, SYGNAL, for dissecting GBM-related causal regulatory
networks and predicting drug targets. The SYGNAL model utilizes
a combination of somatic mutation profiles, inferred TF physical
binding map and gene co-expression to infer TF and microRNA
(miRNA) regulatory relationships, filters for experimentally
supported edges, and uses network edge orientation to infer
causality in the network. While the SYGNAL pipeline highlights
key regulatory links (e.g., IRF1-IKZF1) in GBM and generates high-
confidence inference on GBM-specific drug-miRNA combinations,
it relies heavily on a thorough compendium of experimental
evidence which may not be readily available for other diseases or
biological processes. In addition, such a largely binary network
model does not allow inference of quantitative changes in tran-
scriptome and cellular phenotype in response to perturbations.
Thus, a common issue insufficiently addressed by current methods
for modeling transcription regulatory networks is the lack of
parameterization that permits functional interpretation of the regu-
latory links and predictive modeling of gene expression and cellu-
lar phenotypes. Such a feature is important for identification of
key regulators that are essential for the survival of cells in a given
state and are thus potential drug targets.
To dissect the TF regulatory circuitry underlying the heterogene-
ity of GBM and construct a model that facilitates generation of
actionable hypotheses for targeting different GBM subtypes, we inte-
grated multiple lines of data and assembled a novel computational
pipeline, Integrative Modeling of Transcription Regulatory Interac-
tions for Systematic Inference of Susceptibility in Cancer
(inTRINSiC). We combined two TF binding networks computation-
ally inferred from tissue-specific chromatin landscape data and TF
binding motifs, and parameterized edges using a nonlinear regres-
sion model built from thermodynamic description of transcription
regulation. Fitting GBM gene expression data from the Cancer
Genome Atlas (TCGA) to our model, we constructed subtype-
specific transcription regulatory networks that explain gene
expression variation and provide a mechanistic view of differential
transcription factor activity. Importantly, we were able to predict
each GBM subtype’s dependency on each transcription factor by
integrating our transcription regulatory model with protein signaling
networks and gene essentiality data in the DepMap project (Meyers
et al, 2017; Tsherniak et al, 2017) and show that perturbing the
expression of a subset of transcription factors may provide subtype-
specific therapeutic benefits.
Results
Nonlinear regression accurately models subtype-specific gene
expression in glioblastoma multiforme tumor samples
To model transcription regulation in different subtypes of glioblas-
toma multiforme, we first constructed a candidate network of puta-
tive TF-gene regulatory interactions and then parameterized each
interaction by fitting a nonlinear regression model to patient tumor
gene expression profiles (Fig 1A and B). In order to infer a candi-
date set of brain tumor-specific regulatory pairs, we leveraged two
sources of information: (i) DNaseI hypersensitivity profiles of brain
tumor cell lines, which chart open chromatin regions that may be
accessible to transcription factors and (ii) the JASPAR transcription
factor binding motif database (Sandelin et al, 2004). We assigned
each TF to each potential target gene by modeling the probability of
a given TF binding to each open chromatin region using the Protein
Interaction Quantification (PIQ) algorithm (Sherwood et al, 2014).
We then expanded this set of candidate TF-target pairs by including
edges from a previously constructed tissue-specific regulatory
network for the central nervous system (Marbach et al, 2016)—the
organ system giving rise to GBM development. Additional details on
data processing and parameter selection for the network construc-
tion process are provided in Materials and Methods. The above
procedures result in a list of candidate TF-target gene pairs that are
binary and unsigned. Next, we inferred the strength and sign of
regulation for each of these pairs using a nonlinear regression model
that describes each target gene’s expression as a sum of basal levels
and additive regulatory effects (in logarithmic space) from its regu-
lator TFs. Here, individual regulatory effects from TFs are based on
a biophysical model of transcription regulation (Bintu et al, 2005),
and we assume independent and saturable action of each TF. The
parameter for each TF’s regulatory effect on each target gene, F,
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indicates the sign and strength of the regulatory interaction, where
an F value greater than 1 implies that the TF activates the target
gene, an F value between 0 and 1 implies repression of the target’s
expression by the TF, and an F value of 1 denotes the absence of
regulatory interactions between a given TF-target pair.
To infer subtype-specific F values, we first classified TCGA
GBM samples into different subtypes using the nearest centroid
method where the subtype centroids are computed as in Verhaak
et al (2010). To account for the recent discovery that the Neural
subtype may be an artifact of normal tissue “contamination”, we
also used a new classification scheme by Wang et al (2017)
comprised of only the Classical, Proneural and Mesenchymal
subtypes, and compared the assignment of subtype labels. We find
that the identity of over 80% of samples are conserved in each
remaining subtype and that the Neural subtype samples were re-
distributed into the other three subtypes in the new classification
scheme (Fig EV1B). We estimated F values for each TF-gene pair
in each GBM subtype by fitting the regression model to subtype-
specific expression profiles in the TCGA GBM dataset and imposing
an L2-like regularization term that penalizes large absolute values
of parameters and prevents overfitting, and used 5-fold cross-vali-
dation to select the best hyperparameters for regularization
strength (Fig EV1C). After running the regression model on the
original and new classification schemes (omitting the Neural
subtype samples in the original scheme), we compared the F value
profiles for each TF between the old and new labeling schemes
and found that there is significant correlation between the two in
all three subtypes (Fig EV1D). This suggests that the regression
pipeline is robust with respect to the differences in sample
numbers in each subtype. We will hereafter use the samples from
all subtypes, except the spurious Neural subtype samples (likely
representing a mixture of multiple cell states), from the original
TCGA classification system for subsequent analyses.
Our nonlinear regression models are capable of accurately
predicting GBM tumor gene expression with high subtype speci-
ficity, as shown by an inter-subtype expression prediction experi-
ment where a subtype mismatch between the model and the data
would result in a significant loss in accuracy of prediction (Fig 1C).
Additionally, F value profiles estimated from the bulk tumor data
used in this study showed a significant correlation with those
derived from subtype-specific single-cell expression profiles (Patel
et al, 2014) (Fig 1D), indicating that neither the dataset nor our
models were significantly biased by artifacts from bulk cell
mixtures. We therefore performed all of our downstream analysis in
this study using the TCGA bulk expression dataset, based on its high
gene coverage and sample abundance compared with sparse single-
cell data. Additionally, we compared models built from an indepen-
dent RNA-seq set of 172 GBM samples from the Chinese Glioma
Genome Atlas (CGGA) project (Wang et al, 2015; Liu et al, 2018)
that were classified using the same method as we did for TCGA
samples and found that there is a significant overlap between the
regulatory edges inferred by the model on the TCGA and CGGA
data. This overlap occurs despite vastly different sample sizes and
expression profiling platforms (Figs 1E and EV1F), suggesting that
the regression models are also robust with respect to the size and
type of expression data used.
A key artifact that may diminish the power of this regression
model is that its capability of capturing TF-target gene regulatory
parameters may be limited to transcription factors showing high
expression variability. We show that this is not the case by plotting
the mean absolute log2-F values for transcription factors against the
coefficient of variation in their expression values (Fig EV1G), which
revealed a non-monotonic relationship between mean regulatory
strength and expression variability. Additionally, such a pattern is
in agreement with the idea that TFs with extremely high regulatory
potentials (high absolute log2 F values, such as E2F family transcrip-
tion factors E2F2 and E2F8) are normally maintained at stable
expression levels, whereas those with medium regulatory strengths
(such as TWIST1 and, interestingly, several HOX family genes) are
variably expressed—possibly to mediate responses to stimuli and
facilitate cell state changes. Figure 1F–H shows clustered heatmaps
of F value profiles of TFs with top average regulatory strengths as
indicated by absolute log2 F values. Several of these TFs, including
GATA1 and SP1, have been suggested to be involved in the progres-
sion and invasiveness of glioblastoma cells (Guan et al, 2012).
Importantly, the same gene is often co-regulated by a cluster of TFs,
suggesting that our regulatory models may be able to capture inter-
actions among TFs, which we will explore in the following sections
of this paper.
Gene expression modeling captures known interactions among
transcription factors
We next asked whether the F values obtained from our nonlinear
regression models are consistent with known biology of transcrip-
tion regulation. We hypothesize that TFs with correlated regulatory
profiles, i.e., F value vectors, are more likely to be interaction and/
or co-regulatory partners (Fig 2A). To test this, we computed a
robust correlation metric between each pair of regulatory profiles
using Random Sample Consensus (RANSAC) outlier detection
(Fischler & Bolles, 1981) and examined the top correlated pairs. The
RANSAC algorithm is used to efficiently estimate the dominant
correlation structure within each pair of F value vectors, while
guarding against extreme F values that may substantially skew
correlation calculated with canonical Pearson’s correlation coeffi-
cient. Here, we first focused on TF pairs that are consistently corre-
lated across GBM subtypes, which indicate that they may be
instrumental for brain-specific transcription regulation or that they
are part of the core transcription regulation machinery in the cell.
Indeed, several well-characterized universal TF interactions emerge
from the highly correlated pairs, an example of which is MYC and
MAX, a pair of transcription co-activators for a large number of
target genes across multiple tissue types. As shown in Fig 2B, MYC
and MAX show tightly correlated regulatory profiles across all three
GBM subtypes. Interestingly, on target genes where MYC shows
repression (pink points), the correlation of its F values with those of
MAX tends to be diminished. This is in line with the known biology
of MYC where instead of MAX it partners with the transcription
factor MAD (not modeled in this analysis) to repress target gene
expression (Amati, 1994; Grandori et al, 2000). When we set
increasingly stringent cutoffs for correlation coefficients, we found
that the top 1% correlated pairs show a significant enrichment of
annotated interactions in the BIOGRID database (Chatr-aryamontri
et al, 2015; Fig 2C, Fisher’s exact test P-value = 1.655 × 1012).
Consistently, the observed level of enrichment significantly exceeds
the range of distribution estimated from random sampling of TF-TF
ª 2020 The Authors Molecular Systems Biology 16: e9506 | 2020 3 of 20
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pairs (1,000 iterations, simulated P-value = 0, Fig 2D). Figure 2E
shows a network of known BIOGRID interactions among the top 1%
correlated TF pairs, where a few well-characterized pairs/hubs,
including CTCF-YY1, HIF1a-Sp1, and the histone acetyltransferase
EP300 that regulate a broad range of target genes, are highlighted in
blue.
As a comparison, we have also constructed GBM subtype-
specific regulatory networks using ARACNe (Margolin et al, 2006;
Lachmann et al, 2016), a mutual information-based method for
inferring regulatory links based on gene expression. We found that
there is minimal correlation between the regulatory parameters
inferred by ARACNe (i.e., estimated mutual information) and F
values from our pipeline (Fig EV2B). This suggests that ARACNe
and inTRINSiC may be exploring vastly different types of regula-
tory interactions. To test if this is the case, we mined for TF-TF
interactions by computing robust correlation coefficients among
the parameters estimated by ARACNe for each pair of TFs. Indeed,
inTRINSiC infers a substantially larger set of TF interactions that
significantly overlap with those inferred by ARACNe (Fig EV2C).
When we examined the number of known BIOGRID interactions
captured by the two methods, as well as those captured by
GENIE3, another commonly used network inference tool that ranks
TF-target regulatory edges using random forest regression impor-
tance metrics (Huynh-Thu et al, 2010) [utilized as part of the
single-cell regulatory network construction pipeline SCENIC (Aibar
et al, 2017)], we find that interactions inferred from all three meth-
ods show significant enrichment of known interactions at increas-
ingly stringent cutoffs for correlation between regulatory profiles (F
value or mutual information vectors, Fig EV2D). Thus, inTRINSiC
shows comparable detection power for regulatory interactions as
two other state-of-the-art tools for building regulatory models. In
addition, inTRINSiC potentially expands the inferred TF-TF interac-
tion space compared with ARACNe in a manner that warrants
further experimental interrogation. A summarized comparison
between inTRINSiC, ARACNe, and GENIE3 is provided in
Table EV1.
Transcription factor repurposing may be responsible for shaping
subtype-specific transcriptomes
After confirming that our model accurately explains gene expression
variation in GBM and that the regulatory parameter F delineates key
features of transcription regulation, we proceeded to investigate
whether GBM subtypes show distinct regulatory landscapes, and if
so, to what extent altered transcriptional regulation explains dif-
ferential expression profiles across subtypes.
To mine for subtype-specific regulatory profiles, we performed a
permutation experiment where subtype labels were randomly shuf-
fled and new subtype-specific regression models were fitted for each
iteration. We looked for TF-target pairs that showed subtype-specific
regulatory parameters that are unlikely to be observed in permuted
data (see Materials and Methods for details). Such an analysis
revealed many TFs that displayed distinct regulatory parameters in
one GBM subtype compared with the other two for the same set of
target genes. We hereafter term such altered behavior “repurposing”
of transcription factors and deemed TFs with the majority of its
targets showing F values unique to a single subtype the “signature
TF” of that subtype. An example of TF repurposing is shown in
Fig 3A, where MXI1 is a Proneural subtype signature TF as defined
above. It can be seen in the heatmap of log2 F values that MXI1
represses a subset of targets only in the Proneural tumor samples.
Plots of the expression of one of MXI1’s targets, ITGA5, against that
of MXI1 itself are shown in Fig 3A. Consistent with the trends in F
values, there is a negative correlation between the expression of
MXI1 and ITGA5 only in the Proneural subtype. To define a regula-
tory signature for each of the three GBM subtypes, each TF that
showed significant single-cell expression levels was assigned a
signature subtype. Since it is likely that the same TF may contribute
to the signature regulatory profiles of multiple subtypes, we
computed a score quantifying the levels of participation of each
subtype’s signature TFs in that subtype, shown as heatmaps in
Fig 3B. Indeed, despite high exclusivity of a subset of signature TFs
(DDIT3 and ELK4 in the Mesenchymal subtype, for example), many
signature TFs show comparable participation in the signature of at
least one other subtype (STAT5B, MYC, and STAT3, etc.). This is
consistent with the fact that the latter type of TFs regulate a broad
range of cellular functions in a tissue-nonspecific way.
Transcription factor activity could potentially shape the differen-
tial gene expression landscapes observed across GBM subtypes in
one of three ways: (i) through altered TF expression per se, (ii)
through differential regulatory strength and directionality (mani-
fested as altered F values), or (iii) a combination of these two mech-
anisms. Since we observed F value profiles that are unique to each
subtype, we were particularly interested in the second mechanism.
To examine the extent to which GBM subtype-specific transcrip-
tomes are explained by subtype-specific TF regulatory parameters,
we identified genes within each subtype’s expression signature
whose TFs showed concomitant repurposing in that subtype (see
Materials and Methods for details). Interestingly, we found that
expression signature genes are significantly enriched for genes that
underwent differential regulation by TFs in all but one subtype
(Fig 3C). Additionally, when we computed the extent to which
◀ Figure 1. Modeling subtype-specific transcription regulation in glioblastoma tumor samples.A Schematic of workflow for compiling a candidate network for GBM-specific transcription regulation.
B Nonlinear regression assigns magnitude and directionality of transcription regulation for each transcription factor-target gene pair through a parameter, F value.
C Inter-subtype prediction matrix, where the regression model from each subtype along a column is used to predict gene expression in another subtype along a row,
and scaled average of the median symmetric mean absolute percentage error (sMAPE) values across top variable genes is visualized as heatmap colors.
D Distribution of correlation coefficients between F value profiles obtained from bulk (TCGA) and single-cell datasets.
E Venn diagrams showing overlap of edges between regression models built from TCGA and CGGA where a transcription factor shows up-regulation (upper row) or
down-regulation (lower row) of its target genes. Shown from left to right are Classical (red), Proneural (green), and Mesenchymal (orange) subtypes, respectively,
and corresponding CGGA subtypes are colored in gray. Fisher’s exact test P-values for Venn diagrams are labeled correspondingly.
F–H Heatmaps of representative subsets of F values for the 3 GBM subtypes (Classical, Proneural, and Mesenchymal, respectively). Rows and columns correspond to
transcription factors and target genes with top absolute log2 F values, respectively.
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target gene expression is correlated with that of their regulators, we
found that there is a significant decrease in the mean correlation
coefficient when comparing genes which are differentially regulated
by TFs across subtypes (manifested as subtype-specific F values)
with those which are not (Fig 3D), further supporting the idea that
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expression. Note that the Classical subtype is an exception here,
likely due to a significantly lower number of genes involved in the
analysis or the possibility that TFs may change regulatory behavior
across different expression levels due to negative feedback mecha-
nisms (Chalard et al, 2009).
An important feature of our transcription regulatory models is
that they allow prediction of gene expression changes when the
expression levels of TFs are perturbed. To further examine the
roles which signature TFs play in shaping and maintaining
subtype-specific transcription landscapes, we next asked whether
perturbation of certain TFs can shift the transcriptome profiles of
one subtype of GBM to another. Such cell state changes may be
particularly relevant in GBM, as GBM cells have been shown to
display phenotypic plasticity where cells transition from the
Proneural to a Mesenchymal phenotype (Fedele et al, 2019), and
that patient GBM cells from the same genetic origin could give rise
to progeny harboring divergent transcriptional states (Neftel et al,
2019). To see if our models can recapitulate transcriptional plastic-
ity in GBM, we designed a recursive algorithm to simulate the
propagation of changes in regulatory effects throughout the tran-
scription regulatory network upon knocking down a given TF (see
Materials and Methods for further details and pseudocode for the
algorithm). Having applied such a perturbation algorithm to the
transcription factor STAT3 (a Mesenchymal signature TF, see
heatmap in Fig 3B), we compared the transcriptome profiles of
patient samples before and after perturbation in a 2-D embedding
(Fig 3E). STAT3 has been suggested to act as a master regulator of
the Mesenchymal phenotype in GBM (Carro et al, 2010). We
hypothesized that loss of STAT3 expression may induce a shift
away from the Mesenchymal phenotype. Indeed, as shown by
orange arrows in Fig 3E, many Mesenchymal samples shifted
toward the Classical cluster upon perturbation of STAT3 (red
arrows), implying that a subset of Mesenchymal GBM samples lose
their established cell states. Interestingly, a few Proneural samples
were redirected (green arrows) toward the Mesenchymal cluster.
This may be due to the observation that STAT3 showed remark-
able signature participation in both the Mesenchymal and Proneu-
ral subtypes (Fig 3B heatmap). Other examples of transcriptomic
shifts toward another subtype in TCGA patients in response to
perturbation of signature TFs include HOXA1 and NEUROG1
(Fig EV2E and Table EV2). Interestingly, when we inspect the
subtype specificity of top shift-inducing TFs, we observe the
largest transcriptome shifts in Mesenchymal subtype samples
(Fig 3E, right panel), suggesting that the Mesenchymal subtype
may represent a metastable state that is hyper-sensitive to diverse
perturbations. Taken together, our signature and perturbation
analyses further support the idea that signature transcription
factors maintain cell states and subtype identity in GBM.
Subtype-specific regulatory profiles in glioblastoma multiforme
may be explained by altered functional partnering among
transcription factors
How do transcription factors switch regulatory behavior on the
same set of target genes across different cell states? A signature anal-
ysis of correlation among regulatory profiles similar to that of F
values offers mechanistic insight into such alterations. Here, we
transition from regulatory signatures, which describe how each TF
differentially regulates each target gene in each subtype, to co-regu-
latory signatures, which capture the correlation structure among the
regulatory capacities of pairs of TFs at multiple target genes in each
subtype. Specifically, we computed RANSAC correlation coefficients
among F value vectors of transcription factors in each subtype and
looked for correlated TF pairs which are unique to each subtype. An
example of subtype-specific co-regulatory profiles that emerge from
the analysis is shown in Fig 4A, where the F values of the transcrip-
tion factors MYB and MSX2 are only correlated in the Mesenchymal
subtype.
We defined a set of co-regulatory signature TFs for each subtype
in a similar way to that used to extract regulatory signatures and
again calculated a participation score for each signature TF across
the three subtypes (Fig 4B). Here, the number of signature co-regu-
latory TFs in each subtype does not seem to correlate with that of
signature regulatory TFs as shown in Fig 3B, suggesting that addi-
tional mechanisms apart from changes in co-regulatory partners are
involved in TF repurposing.
For a global view of differential TF-TF partnering, we plotted
circos (Krzywinski et al) diagrams representing top correlations
between the F value profile of each co-regulatory signature TF with
that of other TFs (Fig 4C, upper panel). It seems that the overall
architecture of such a co-regulatory network is largely conserved
across GBM subtypes (Fig 4C, upper panel and Fig EV2A). When
we focused on individual signature TFs, however, local rewiring of
the co-regulatory network emerged, for example in the case of the
Proneural co-regulatory signature TF, MXI1 (Fig 4C, lower panel).
Interestingly, MXI1 is also a regulatory signature TF as determined
in the previous section. In fact, there is a significant overlap
between the regulatory and co-regulatory signature TF sets (hyper-
geometric test P = 0.011, with overlapping TFs shown in Venn
diagram in Fig 4D), suggesting that the altered behavior of several
TFs could be due to differential coordination with other TFs. To see
if this was the case, we examined the correlation of F values across
◀ Figure 2. Nonlinear regression models capture known interactions among transcription factors.A Schematic of workflow for inferring TF-TF interactions.
B Scatter plot showing consistent correlation between the regulatory profiles (F values) of MYC and MAX across all three subtypes. Pearson correlation coefficient (R2)
values are shown. Regions where MYC shows negative regulation of gene expression (hence likely to be interacting with MAD rather than MAX) and MAX shows no
significant regulation are shaded pink, with threshold for negative regulation shown as dotted horizontal lines.
C TF-TF pairs with top F value correlations are enriched for known interactions in the BIOGRID database. P-value for Fisher’s exact test of proportion of known
interaction pairs among top 1% correlated TFs compared to selecting all possible interaction pairs is shown.
D Distribution of prediction precision of known BIOGRID interactions from 2,000 randomly drawn TF pairs (histogram) compared with those predicted from TF pairs
with top 1% F value correlation (vertical line). Simulated P-value is 0.
E Network representation of captured known BIOGRID interactions from top 1% F value correlation coefficients. A subset of nodes participating in well-characterized
interactions, including CTCF-YY1 and dense interaction subnetwork of EP300, is colored in blue.
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target genes which undergo differential regulation across subtypes.
Indeed, we found that several co-regulatory TFs showed signifi-
cantly different distributions of correlation coefficients with other
TFs at target genes which were differentially regulated (Fig EV6).
Figure 4E shows the example of MXI1 (left panel), where additional
correlations, or partnerships, with other TFs are gained in the
Proneural subtype. This suggests that analyses of F values could
pinpoint changes in the coordinated action of TFs at specific target
genes that, in turn, altered the regulatory strength and/or direction-
ality of particular TFs. For TFs that did not show subtype-specific
co-regulatory partnerships at differentially regulated target genes
(for example the glucocorticoid receptor NR3C1, a Mesenchymal
signature TF, see Fig 4E right panel), possible mechanisms may
include trans-repression, where a TF can achieve indirect repression
of target genes by associating with other activator TFs and prevent
them from binding to their respective regulatory regions, as in the
case of NR3C1(Ray & Prefontaine, 1994).
Integrated transcription regulation-protein signaling network
models enable in silico screening for gene essentiality and infer
new therapeutic targets in glioblastoma multiforme
Having established that our transcription regulatory models could
both accurately capture gene expression variation and provide
mechanistic insights into the mode of action of transcription factors,
we next sought to build a novel, integrated pipeline for predicting
phenotypic output of TF perturbations beyond transcription and
dissecting subtype-specific dependencies in glioblastoma. A sche-
matic of this subroutine and its relationship with other components
of the inTRINSiC pipeline is shown in Figs 5A and EV5. Specifically,
the effects of transcription regulation (i.e., gene expression values)
are overlaid onto a protein signaling network, where a random
walk-based algorithm termed Exponential Ranking (Traag et al,
2010) is employed to estimate the activity level of each protein (see
Materials and Methods for a detailed description of the algorithm).
Our method differs from existing protein activity scoring algorithms
such as VIPER (Alvarez et al, 2016) in that it does not rely on
strengths of transcription regulation as a “readout” for protein activ-
ity, i.e., instead of assessing how much a regulator ultimately
changes the expression of other genes (as in VIPER, which is
coupled to output from ARACNe), we use gene expression values
(computed by the nonlinear regression models of inTRINSiC) and
direct protein–protein signaling interactions to estimate the relative
activity levels of proteins based on the strength and nature of the
interactions. When comparing protein signaling activity estimated
from VIPER and that from our exponential ranking method, we
found that exponential ranking was able to estimate protein activity
changes for all 3,132 proteins covered by our signed, weighted
model whereas VIPER only covered 218 proteins deemed as master
regulators by the algorithm (Fig EV2F). Additionally, among the
covered interactions, VIPER did not capture some of the well-estab-
lished signaling activities, such as the EGFR/STAT3 and EGFR/
KRAS axes, where EGFR is expected to activate these two down-
stream targets (Fig EV2G and H).
Using such a framework for simulating perturbation of TF
expression as well as information flow in the cellular circuitry, we
fitted our regulatory models to 32 brain tumor cell lines (using a
training-validation set split of 24-8 and 4-fold cross-validation) in
the CCLE cell line collection (Barretina et al, 2012), which can each
be assigned an expression subtype based on proximity to centroids
extracted from TCGA tumor data (Fig EV3A and B, see Materials
and Methods for details). We first performed Exponential Ranking
on these 32 cell lines to estimate protein activity levels. To infer
effects of knocking down individual TFs, we then perturbed the
expression of each TF using our recursive algorithm. A new set of
protein scores were then computed based on new expression levels
obtained from the perturbation. Next, we trained an elastic net
regression model for each perturbed TF to find a sparse linear
combination of proteins, the changes in whose activity best predict
the TF’s gene essentiality, as quantified by depletion scores in the
DepMap genetic screen dataset (Materials and Methods).
Our training-validation pipeline identified a set of protein activity
changes, following in silico perturbation of TFs, that could poten-
tially predict TF essentiality in individual cell lines. We tested these
predictions on eight independent CCLE cell lines that were not
included in our initial training-validation set. Our regression models
were able to predict essentiality scores that were highly consistent
with experimentally determined scores for the majority of TFs
examined in this study (Fig 5B showing TFs ranked by the inverse
root mean square error of predicted essentiality scores, and Fig 5C,
with mean correlation deviating significantly from 0, Wilcoxon rank
sum test P-value = 4.99 × 1029). Figure 5C also shows the four
TFs with lowest prediction error (Fig 5B) and highest correlation
between predicted and DepMap essentiality scores. Additionally,
essentiality scores predicted by our pipeline show consistent
subtype specificity with experimentally determined DepMap essen-
tiality scores (Fig 5D). In other words, TFs that we identified previ-
ously as core contributors to subtype specificity also show subtype
◀ Figure 3. GBM tumor samples exhibit unique transcription factor regulatory profiles that shape subtype-specific gene expression landscapes.A Left panel: heatmap of signature F values on a log2 scale for MXI1, a Proneural subtype signature transcription factor. Right panel: gene expression plots of ITGA5, a
signature target gene of MXI1 (highlighted in green box in left panel), against that of MXI1, across the three GBM subtypes. Density clouds are overlaid onto scatter
plots, and a dashed linear regression line is shown for each subtype.
B Heatmaps showing participation of each subtype’s signature TFs in the corresponding subtype signature. Color scale corresponds to the proportion of TF-target gene
pairs that show consistent signature behavior with the corresponding subtype signature among all TF-target pairs that show any signature behavior.
C Pie charts showing proportion of target genes that show differential regulation by TFs, comparing all target genes (upper panel) with those that are differentially
expressed among the subtypes (i.e., subtype expression signatures, lower panel). P-values from hypergeometric tests for enrichment of differentially regulated target
genes among expression signatures in each subtype are shown.
D Kernel density estimations of average correlation coefficients between target genes and their corresponding transcription factors. P-values for Mann–Whitney tests
comparing each pair of distributions are shown.
E Left panel: perturbation of STAT3 induces Mesenchymal samples to shift toward the Classical subtype cluster. Each arrow points from the TCGA sample before
perturbation to the same sample after perturbation, projected onto a 2-dimensional Uniform Manifold Approximation and Projection (UMAP) space. Right panel: pie-
chart showing distribution of the subtype showing the largest overall shift among the 50 TFs that induce the largest subtype-specific shift.
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essentiality. Interestingly, patterns in the regression coefficients
(Fig EV4A and B) imply that a subset of TFs share common predic-
tor proteins, suggesting that the effects of perturbing these TFs are
likely to be mediated by common pathways. On the other hand, the
same TF’s knockdown effects may be mediated by a multitude of
proteins, which is consistent with the notion that perturbing a single
TF may result in pleiotropic effects throughout the intracellular
signaling network that collectively reduce fitness of the cell.
Having confirmed that the effect of knocking down at least a
subset of the TFs can be accurately predicted by combinations of
changes in protein scores, we next asked if such a model could
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is intractable to perform individual unbiased genetic screens. We
normalized the CCLE and TCGA expression datasets to remove
batch effects and ran the perturbation—regression pipeline
described above on the CCLE subset to obtain regression coefficients
for each protein. Using the same coefficients, we computed the
expected knockout/knockdown depletion score (i.e., gene essential-
ity score) for each TF in individual TCGA GBM tumor samples. We
observed that the knockdown of certain TFs confers significantly
different predicted levels of survival disadvantages across subtypes,
examples of which include MYBL2 (Fig 5D) and NFE2 (Fig EV4C,
see Table EV3 for a full list of predicted subtype-specific survival
disadvantages for each TF). We found six transcription factors with
predicted subtype-specific essentiality scores that also show consis-
tent subtype-specific negative correlation between their expression
levels and tumor patient survival (Fig 5E). Here, we focus on
MYBL2, whose knockdown is significantly more detrimental to the
Proneural subtype than to the other subtypes in silico (one-way
analyses of means P-value 1.51 × 1061, df = 2.0, df2 = 215.3).
Consistently, we only see a negative correlation between MYBL2
expression and survival in the Proneural subtype samples (Fig 5F).
In addition, log-rank tests of survival of MYBL2-high versus MYBL2-
low patients in the TCGA dataset (as demarcated by median expres-
sion within each subtype) show that MYBL2-low patients show
significantly higher survival rates only in the Proneural subtype
(log-rank test P = 0.035, Figs 5G and EV4D). We observed a simi-
larly significant trend in an independent set of 172 GBM samples
from the Chinese Glioma Genome Atlas (CGGA) project (Wang
et al, 2015; Liu et al, 2018), where low MYBL2 levels correspond to
higher survival only in the Proneural subtype (log-rank test
P = 0.028, Figs 5G and EV4D). Interestingly, our F value correlation
analysis showed that MYBL2 displays high correlation with the
Proneural signature TFs TFCP2 and MXI1, suggesting that subtype-
specific TF interactions may be key to maintaining cell state and
viability in the corresponding subtype. The above analyses demon-
strate that the inTRINSiC pipeline is capable of identifying potential
subtype-specific drug targets for GBM, for example MYBL2 in the
Proneural subtype.
Discussion
We propose a computational framework, inTRINSiC, for integrating
epigenomic, transcriptomic, protein interaction, and genetic pertur-
bation data to dissect tumor heterogeneity in glioblastoma multi-
forme and use this framework to systematically infer subtype-
specific vulnerabilities. inTRINSiC serves as a powerful, tractable
platform for distilling large-scale omics data into candidate genes
that are critical for different cell states and generating actionable
hypotheses for targeting tumors in a subtype- and even patient-
specific way.
We first showed that transcription regulation by TFs can be
quantitatively described using biophysical models, which despite
simplifying assumptions was still able to accurately capture gene
expression variation across GBM subtypes (Figs 1C and EV1C) as
well as TF-TF co-regulatory interactions (Fig 2C and D), which are
not explicitly factored into the model. In addition, bulk tumor
expression data did not seem to significantly confound our analysis
despite cell state mixture effects, as models built from single-cell
expression data showed significant consistency with those from
bulk data (Fig 1D). Note that a small subset of transcription factors
(e.g., FOSB and RXRA in Classical and Proneural subtypes) showed
near-zero or negative correlation between bulk and single-cell F
value profiles, possibly due to immune cell and/or normal brain
tissue infiltration of tumors in bulk samples. However, these incon-
sistencies did not seem to significantly confound our downstream
analyses, since the TFs that showed such behavior did not partici-
pate in the signatures discovered for each subtype or score as top
essential TFs. We were also are able to uncover subtype-specific
regulators, consistent with single-cell expression-based discoveries,
for example DDIT3 in the Mesenchymal subtype (as seen in Neftel
et al, 2019 and Fig 3B). Compared with existing regulatory network
inference methods such as the information theory-based ARACNe
package (Margolin et al, 2006; Lachmann et al, 2016), and the
correlation-based models tailored for single-cell expression data by
SCENIC (Aibar et al, 2017; see Table EV1 for a summarized compar-
ison of methods and Fig EV2D for a comparison of performances), a
distinct feature of the nonlinear regression method used in the
inTRINSiC pipeline is that it explicitly models the quantitative regu-
lation of steady-state gene expression by transcription factors. While
such a model may be oversimplifying the intricate process through
which gene expression is modulated and relies substantially on the
availability of physical binding/chromatin accessibility and TF motif
data, it yields easily interpretable parameters that directly corre-
spond to the maximum fold change (as well as the directionality of
change) a given TF can induce in its target gene expression. These
parameters and their resulting quantitative output are not explicitly
modeled in other pipelines. Additionally, even without direct model-
ing of higher-order interactions between TFs, the inTRINSiC pipeline
is still able to capture TF-TF co-regulatory interactions that are not
as effectively recovered in linear methods (Fig EV1C).
◀ Figure 4. Subtype-specific co-regulatory interactions among TFs may explain differential regulatory behavior.A Scatter plot showing consistent correlation between F value profiles of MSX2 and MYB across each subtype. Robust regression lines (dashed lines in each panel) as
well as Pearson correlation coefficient (R2) values are shown. Density clouds are overlaid onto scatter plots to highlight trends.
B Heatmaps showing participation of each subtype’s signature TFs in the corresponding subtype TF-TF co-regulatory signature. Note that here instead of F values of
TF-target regulation, signatures are derived from correlation coefficients of F value profiles between pairs of TFs across subtypes. Color scale corresponds to the
proportion of TF-TF co-regulatory pairs that show signature behavior consistent with the corresponding subtype signature among all TF-TF pairs that show any
signature co-regulatory behavior.
C Upper panels: circos diagrams showing all top co-regulatory partners (gray nodes along the outer circle) inferred for subtype signature TFs (colored nodes along the
outer circle). TF pairs with F value correlation coefficients larger than 0.8 are visualized as links. Lower panels: same TFs but only showing links originating from MXI1,
a Proneural subtype signature TF.
D Venn diagram showing overlap between regulatory and co-regulatory signature TFs, colored according to GBM subtypes.
E Kernel density plots of correlation coefficients of signature TFs MXI1 (Proneural) and NR3C1 (Mesenchymal) with other TFs at differentially regulated target genes.
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It is important to note here that regulation by transcription
factors is only one of several mechanisms of gene expression
control, and other factors including miRNAs and long non-coding
RNAs may also play significant roles. However, we did not include
non-coding mRNAs in our current version of inTRINSiC pipeline for
two reasons: (i) the effects of miRNA regulation are estimated to
explain only 7–13% of overall gene expression variation (Vejnar &
Zdobnov, 2012) and (ii) since miRNAs act primarily via repressing
mRNA levels (Guo et al, 2010), regulation by miRNAs may be
absorbed into TF regulation in our model where a subset of TF-
target regulatory parameters may be due to indirect regulation of
the target by TFs through expression of miRNAs (Guo et al, 2010).
This does not preclude that certain miRNAs may represent critical
nodes of regulation or that the inclusion of miRNA data in the future
may refine our analysis. In our current version of inTRINSiC, we
also did not explicitly model the effects of genetic alterations on
transcription regulation. This was due to a lack of systematic cata-
logues documenting how specific mutations affect transcription
factor functions. In addition, the relatively low frequency of muta-
tions and their uneven distribution across subtypes would signifi-
cantly diminish the statistical power in our regression models.
However, we do expect the effects of mutations to be implicitly
modeled by F values, as transcription factors whose regulatory
activities are affected by mutations are likely to display altered F
value profiles. In fact, our regulatory/co-regulatory signature analy-
ses hint at effects potentially mediated by genetic alterations. For
example, MYC, which shows a Mesenchymal-specific co-regulatory
profile (Fig 4B), has been previously shown to be upregulated by
EGFR signaling and induce transition to a mesenchymal phenotype
(Dong et al, 2018). Interestingly, such a signature is not seen in
other subtypes where the EGFR mutations are enriched (Verhaak
et al, 2010).
An important feature of the regulatory models built from the
inTRINSiC pipeline is that aside from differentiating between dif-
ferent GBM subtypes in terms of the behavior of each TF (Fig 3B),
they also provide clues as to the potential mechanisms of the same
TF switching regulatory behavior on the same set of target genes
(Fig 4). Specifically, we found that despite conservation of the
majority of TF-TF partnering relationships (Fig EV2A), TFs that are
part of a subtype signature tend to display local, differential partner-
ing with other TFs across proximal regulatory regions of target
genes, implying that the regulatory heterogeneity observed across
GBM subtypes may be a result of differential physical clustering of
TFs at promoters/enhancers. Importantly, it has been shown that
the transcription factor STAT3 (a Proneural/Mesenchymal signature
TF inferred by inTRINSiC) and its associated signaling network play
key roles in promoting an immunosuppressive tumor microenviron-
ment that may hinder immunotherapy (See et al, 2012; Jackson
et al, 2011). It would thus be interesting to further investigate the
multitude of co-regulatory relationships predicted by inTRINSiC. We
demonstrated that the combinatorial changes in the action of TFs
could explain a significant proportion of differential expression
observed across GBM subtypes (Fig 3C and D).
Finally, we performed an in silico screen for each subtype’s
dependency on different transcription factors by simulating informa-
tion flow from the transcription regulation layer to the protein
signaling layer and learning combinatorial protein activity that best
predicts known gene essentiality scores (Fig 5), and uncovered TFs
that display GBM subtype-specific essentiality. Such a functionality
is unique to the inTRINSiC pipeline due to predictive models of tran-
scription regulation and is not encompassed by other integrative
pipelines such as SYGNAL (Plaisier et al, 2016; Table EV1). Another
feature of this second part of the inTRINSiC pipeline is that the
method for protein signaling activity inference is uncoupled from
that of transcription activity—we trimmed all edges that only
belongs to the “transcriptional regulation” category in the signaling
networks for this step such that TF regulatory effects are required to
be modeled by the TF-target network construction part of
inTRINSiC, and only signaling/post-translational regulation activi-
ties are explicitly modeled in the downstream protein network. Such
a strategy ensures consistency with known signaling relationships
and achieves a larger coverage of signaling proteins than methods
that infer protein activity based on transcriptional “regulons”, such
as VIPER (Fig EV2F–H). The TFs deemed essential by inTRINSiC
can in turn be prioritized for further experimental validation in rele-
vant cell lines or patient derived xenografts (PDXs). Key advantages
◀ Figure 5. Integrated multilayer regulatory network model enables in silico perturbation and inference of subtype-specific drug targets in GBM.A Schematic of in silico perturbation through multilayer network information flow simulation. Left: changes in gene expression induced by perturbation of a TF can be
estimated through transcriptional regulatory models, and propagated to the protein signaling network, where a modified random walk algorithm scores signaling
activity. Middle: iteratively perturb each TF and generate a matrix of perturbed signaling scores. Right: optimal “readout” of effects of TF perturbation on fitness can
be learned through known genetic screening data such as DepMap gene essentiality scores.
B Transcription factors ranked by the prediction accuracy in test set cell lines (y axis, plotted are 1 over root mean squared error values) of their essentiality when
compared to DepMap scores.
C Left panel: histogram of correlation between predicted and DepMap TF essentiality scores. Right panel: experimentally determined (DepMap) versus predicted gene
essentiality scores for TFs where a linear combination of protein signaling activity scores could predict TF essentiality with high accuracy. Data points are color-coded
according to subtype labels (red—Classical, green—Proneural and orange—Mesenchymal).
D Upper left panel: subtype specificity of predicted versus DepMap essentiality scores. Three TFs with top consistent specificity values are highlighted in a box region.
Remaining panels: bar plots showing mean  standard error of the mean (SEM) of DepMap (gray) and predicted (color-coded according to subtypes as in (C))
essentiality scores, grouped by subtypes. # of cell lines in each subtype: Classical—11, Proneural—4, Mesenchymal—25. Paired Student’s t-test P-values for each
paired set of DepMap-predicted results are non-significant after Bonferroni correction except for the Proneural subtype in SOX2 perturbations (*P = 0.044).
E Heatmap of correlations between TF expression and TCGA patient survival in each subtype. Shown are the six TFs that are consistent in terms of the most dependent
subtype predicted by inTRINSiC and the subtype showing the most negative correlation between TF expression and patient survival.
F Box and jitter plots of predicted essentiality scores of MYBL2 in TCGA tumor samples grouped by subtype. Box plots show 25th, 50th, and 75th percentiles, and whiskers
extend up to 90th and down to 10th percentiles. # of samples: Mesenchymal—165, Proneural—103, Classical—139.
G Kaplan–Meier survival curves of TCGA and CGGA Proneural GBM samples, grouped by MYBL2 score (high versus low demarcated by median expression). # of patients
in TCGA Proneural subset: MYBL2-high—47, MYBL2-low—48. # of patients in CGGA Proneural subset: MYBL2-high—24, MYBL2-low——25. Log-rank test P-values are
shown. Survival curves for the remaining subtypes are provided in Fig EV4D.
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of such an in silico perturbation system include obviation of in vivo
screens in PDX samples which may not engraft well, and prediction
of tumor susceptibility on an individual sample basis. Indeed, we
describe a work flow by which data from functional studies on
cancer cell lines, like the DepMap, can be readily applied to emerg-
ing patient tumor data from diverse sources to identify subtype-
specific vulnerabilities. While these vulnerabilities are TFs, a set of
proteins that are notoriously difficult to target using small mole-
cules, this approach may also converge upon druggable downstream
targets of TFs. Additionally, there has been significant promise in
the development of new strategies to target transcriptional regula-
tors and TF interactions (Bushweller, 2019).
In this study, we identified MYBL2 as a transcription factor
essential for the Proneural subtype. Interestingly, in a separate anal-
ysis of GBM subtype-specific regulatory programs, MYBL2 was also
identified as a signature regulator of the Proneural subtype (Setty
et al, 2012). MYBL2 is a member of the MYB family of transcription
factors that plays important roles in cell cycle progression and main-
tenance of cells in an undifferentiated state (Musa et al, 2017). Its
functions oppose that of ASCL1—a transcription factor promoting
neuronal differentiation—and putatively crucial to maintaining the
Proneural transcription landscape (Narayanan et al, 2019), which is
consistent with the observation that overexpression of ASCL1
in vitro (Narayanan et al, 2019) and knockdown of MYBL2 in silico
(this paper) are detrimental to Proneural subtype cells. Additionally,
the fact that the subtype-specific essential TF MYBL2 is also implied
to be functional interaction partners with the corresponding
subtype’s signature TFs further supports the idea that our signature
analyses are capable of capturing GBM subtype-specific biology.
The inTRINSiC pipeline extends beyond GBM and serves as a
new paradigm for understanding disease heterogeneity and dif-
ferent cell states through an integrated, multilayer network of
transcription and protein activity regulation (Fig EV5). It is a
flexible platform in that additional layers of regulation, including
chromatin modifications and enhancer regulations, can be readily
factored into the transcription regulation models wherever tissue-
specific data are available. Additionally, with improvements in
the scale and coverage of newer techniques such as Perturb-seq
and single-cell epigenomics, the inTRINSiC pipeline can be
extended to distinguish the source of phenotypic heterogeneity at
the single-cell level through modeling multiple layers of regula-
tion in the same cell (Fig EV6).
Materials and Methods
Reagents and Tools table
Reagent/Resource Reference or Source
Software
CRAN R version 3.6.3 or higher https://cran.r-project.org/ (R Core Team, 2013)
RStudio version 1.2.5042 or higher http://www.rstudio.com/ (RStudio Team, 2020)
Python 2.7 or higher http://www.python.org
scikit-learn package version 0.22.1 or higher https://scikit-learn.org/stable/index.html (Pedregosa et al, 2011)
MATLAB r2016a or higher with MATLAB
Compiler (MCC)
https://www.mathworks.com/products/matlab.html
circos version 0.69 or higher https://circos.ca (Krzywinski et al, 2009)
Cytoscape Version 3.7.1 or higher http://www.cytoscape.org (Shannon et al, 2003)
GraphPad Prism version 6 or higher https://www.graphpad.com/scientific-software/prism/
Protein Interaction Quantification (PIQ)
algorithm software package
https://bitbucket.org/thashim/piq/src/master/ (Sherwood et al, 2014)
Resources
TCGA GBM gene expression & survival datasets https://www.cancer.gov/tcga
CGGA GBM gene expression & survival datasets http://www.cgga.org.cn/ (preprint: Zhao et al, 2020)
ENCODE glioma cell line DNaseI-seq datasets https://www.encodeproject.org/
ENCODE Project Consortium (Dunham et al, 2012), ENCODE data portal (Davis et al, 2018)
Accession codes: ENCFF338CJE, ENCFF422GJX, NCFF899YRC, ENCFF175YAU, ENCFF251KOI, ENCFF397OZE,
ENCFF001DWK, ENCFF001CAA, ENCFF001DWM
FANTOM5 CNS-specific regulatory networks https://fantom.gsc.riken.jp/5/ (Lizio et al, 2019, 2015)
JASPAR motif database, fifth expansion http://jaspar.genereg.net/ (Mathelier et al, 2016)
CCLE expression datasets (v2018q2) https://portals.broadinstitute.org/ccle/data (Barretina et al, 2012)
DepMap gene essentiality dataset (v2018q2) https://portals.broadinstitute.org/ccle/data (Tsherniak et al, 2017; Meyers et al, 2017)
STRING human protein interactions network
v11
https://string-db.org/ (Szklarczyk et al, 2019)
14 of 20 Molecular Systems Biology 16: e9506 | 2020 ª 2020 The Authors
Molecular Systems Biology Yunpeng Liu et al
Reagents and Tools table (continued)
Reagent/Resource Reference or Source
BIOGRID human protein interactions network
v3.4.158
https://downloads.thebiogrid.org/BioGRID/Release-Archive/BIOGRID-3.4.158/ (Oughtred et al, 2019)
FunCoup human protein interaction database
v4.1
http://funcoup.sbc.su.se/downloads/ (Ogris et al, 2018)
Methods and Protocols
A combined overview of the steps involved in the inTRINSiC model-
ing framework is shown as a schematic in Fig EV5. Here, we
provide a step-by-step walkthrough of the procedures involved,
from gene expression, epigenomics, motif and previously compiled
tissue-specific network datasets to ultimately predicting transcrip-
tion factor essentiality in different GBM subtypes.
Reconstruction of the GBM transcription regulatory network
To obtain a backbone regulatory model that is specific to the tissue
of origin in glioblastoma multiforme (GBM) and encompasses as
many potential regulatory edges as possible, we assembled a tran-
scription regulatory network model for brain tissue using publicly
available tissue-specific models from the FANTOM5 project (Mar-
bach et al, 2016) and augmented the network with another one
inferred from motif and chromatin landscape information specific to
brain tumor cells. For the FANTOM5 brain network, we used the
union of all networks built from brain tissues covered in the project,
retaining top 10% edges in each network. The cutoff was arbitrarily
selected to control model size and did not significantly reduce cover-
age of expressed genes and transcription factors (see network statis-
tics reported below). We describe details of the procedures for
inferring the latter network in the following.
We first retrieved DNase hypersensitivity sequencing (DHS-seq)
datasets in four human brain tumor cell lines (Daoy, H4, A172, and
M059J) from the ENCODE project (Davis et al, 2018). Analysis of
expression data for these cell lines from the Cancer Cell Line Ency-
clopedia (CCLE) (Barretina et al, 2012) database shows that their
transcriptomes fall close to those of TCGA patient samples and
resemble those of one or more GBM subtypes (Fig EV3A and B),
and are thus phenotypically relevant to our model. Next, combining
DHS-seq data that chart open chromatin landscapes in these cell
lines and position weight matrices (PWMs) from 579 motifs in the
JASPAR motif database (Sandelin et al, 2004), we inferred potential
regulatory edges from 518 transcription factors (TFs) to target genes
using the Protein Interaction Quantitation (PIQ) algorithm (Sher-
wood et al, 2014). Briefly, we applied the algorithm to each cell
line’s DHS-seq data to assign likelihood scores of proteins (TFs)
binding to open chromatin regions, and selected interactions within
the top 10% of all scores to obtain a motif-region map for that cell
line. The percentage cutoff was chosen to roughly match the size of
the brain-specific network and minimize biases introduced by gene
coverage (Fig EV1A). Motif-region maps are then converted to TF-
gene maps using the closest gene method, where a TF is assigned to
the gene(s) closest to its open motif(s) within a  10,000 bp
window from the transcription start site. Note that this method is
likely to favor selection of promoters and proximal enhancers. The
above pipeline resulted in four separate regulatory networks based
on motif binding likelihood, and the union of three networks was
computed for the final brain tumor-specific DHS network. Here, we
excluded the network built from M059J data due to the significantly
smaller number of edges, probably due to insufficient sequencing
coverage.
Prior to all analyses, we filtered the networks for genes whose
expression data are available. GBM microarray gene expression data
were retrieved from the Cancer Gene Atlas (TCGA) data portal as of
July 2014. The expression dataset has not been significantly revised
since then and we chose microarray expression due to a larger subset
of patients covered. The RMA-normalized expression matrix consists
of 544 patient samples and 12,042 genes. After filtering, the union-
ized DHS network from four brain tumor cell lines consists of
494,860 edges from 424 TFs to 10,388 genes. When we compared the
DHS network with that of the brain-specific FANTOM5 network
constructed by Marbach et al (2016) (containing 201,095 edges from
460 TFs to 10,050 genes after expression filtering), we see that there
is only a small overlap between the two (~ 5% of the DHS network
covered by FANTOM5 network). This does not seem to be due to
systematic biases in the coverage of regulatory edges by the DHS
data, as the DHS-based network showed an enrichment of FANTOM5
edges with increasing binding score cutoffs for controlling network
size (Fig EV1A). The final backbone network we used for regression
is the union of these two filtered networks, containing 653,800 edges
from 518 TFs to 10,733 genes.
GBM subtype-specific parameterization of regulatory interactions
using nonlinear regression
To understand regulatory heterogeneity in GBM, we set out to
assign biologically meaningful parameters to the backbone regula-
tory network and select edges that display strong regulatory capaci-
ties using a nonlinear regression model. Our model is built upon a
thermodynamic description of transcription regulation by Bintu et al
(2005) and assumes the following conditions: (i) each transcription
factor (TF) acts upon each target gene in a nonlinear, saturable
association with its own expression, (ii) effects of transcription regu-
lation of different TFs on the same target gene are independent of
each other and (iii) effects of different transcription factors are
multiplicative (additive in logarithmic space). Denote the expression
vector (comprised of K samples) of a given target gene i and each
TF j (j 2 {ni1, ni2, . . ., nir}) of its r candidate regulatory TFs (as
dictated by the backbone network) as yi
! and xi!, and let xi0 be the
basal level of gene expression without regulation from any of the
candidate TFs, we have:
log2 yi







where vector operations are element-wise. The single parameter
for each TF-gene pair Fji can be thought of as the regulatory capac-
ity of TF j for gene i and theoretically determines the maximum
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amount of fold change TF j can induce upon the expression of gene
i. Specifically: (i) if Fji > 1, gene i is activated by TF j, (ii) if Fji < 1
gene i is repressed by TF j, and (iii) if Fji = 1, TF j has no regula-
tory effect on gene i.
The above model is fitted to expression data from all samples
in each GBM subtype using the limited memory-BFGS method
(Liu & Nocedal, 1989) in MATLAB with an L2-like penalty term,
where subtype class labels are assigned to each of the TCGA
GBM samples using the nearest centroid method based on expres-
sion cluster centroids published in the original works of Verhaak
et al (2010). To filter for truly subtype-specific TF-target relation-
ships, we shuffled the subtype labels 30 times and re-computed
the F values using the same number of samples per label group,
and looked at the unshuffled F values showing deviation from the
shuffled F values of at least 5 standard deviations. To classify all
central nervous system (CNS) tumor cell lines in the CCLE
DepMap dataset into relevant GBM subtypes, we first normalized
CCLE cell line expression data against the TCGA GBM expression
dataset using the RemoveBatchEffects function in the R limma
package and standardized all expression data to have a mean of
zero and standard deviation of 1. We observe that the CCLE
samples mix well with TCGA samples after normalization
(Fig EV3A and B). We then used a nearest centroid method to
classify CCLE cell lines using the subtype signature genes and
their reference expression centroids as determined by Verhaak
et al Similarly, for inferring F values from the CGGA dataset, we
first performed batch effect removal using the R limma package
to normalize log2-transformed CGGA RNA-seq expression data to
have similar distribution to that of the TCGA microarray expres-
sion data before assigning subtype labels and inputting subtype-
specific expression to the regression pipeline. We lay out details
of hyperparameter selection for the nonlinear regression in the
following step.
Hyperparameter selection for parameterized GBM subtype-specific
regulatory network
To prevent overfitting the nonlinear regression, we imposed an
L2-like penalty term that results in the following objective
function:




j2 ni1 ;ni2 ;...;nirf g
ðlog2 yik  log2 yik;obsÞ2
þk P
j2 ni1 ;ni2 ;...;nirf g
ðlog2 FjiÞ2;
where the expression estimate of gene i in sample k, yik, is
computed using equation 1 in the Materials and Methods section
of this paper, and logarithm values are used for numerical stability.
The hyperparameter lambda determines the strength of the penalty
on large F values that may dominate the regulatory profile of a
given transcription factor (TF). We chose a final lambda value of
0.1 which achieved a low gene expression value prediction error in
5-fold cross-validation as well as the highest area under curve of a
precision-recall curve constructed by computing the amount of
known TF-TF interactions captured by each model (Fig EV1C, see
the next section for details of TF-TF interaction prediction). As a
comparison, we computed the same metrics for a simple linear
model (trained using L2-regularized regression) for predicting gene
expression, and Fig EV1C (black curve) shows that the nonlinear
model is superior to the linear model across a broad range of regu-
larization strengths.
Extraction of correlated regulatory profiles
As previously mentioned, our regression model for parameterizing
transcription regulation does not explicitly model interactions, i.e.,
effect of each TF on the target gene is independent of one another.
Nonetheless, we anticipated correlation structures to emerge from
the F value profiles of TFs since we fit a regression model to the
expression of each gene independently. To compute a robust corre-
lation strength for each pair of F value vectors (each corresponding
to the regulatory profile of a TF across all target genes), we first
eliminated target genes that were not regulated by either one of the
TFs to reduce zero inflation. We then eliminated potential “outliers”
by using the Random Sample Consensus (RANSAC) regression algo-
rithm implemented in the scikit-learn Python package (Pedregosa
et al, 2011), using a minimum of 80% of samples to determine
outliers. As discussed in the main text, the RANSAC method helps
capture the core correlation structure and prevents large biases orig-
inating from a small subset of extreme F values. Correlation was
then computed as the Pearson correlation coefficient between the
trimmed F value vectors if their lengths are greater than 3, and set
to 0 otherwise.
Inferring protein activity from an integrated transcription
regulation-signaling network
We first constructed a protein signaling network containing edges
between protein pairs with annotated activating or inhibitory inter-
actions in two databases: STRING (Szklarczyk et al, 2015) and
FunCoup (Schmitt et al, 2014). The former database provides
signed, unweighted links, and the latter provides likelihood scores
for interaction between each protein pair, inferred through Bayesian
integration of multiple lines of evidence. The final signaling network
consists of 20,473 signed and directed links among 3,132 proteins in
the STRING network that have been assigned a likelihood score by
the FunCoup network. To infer protein signaling activity, we used a
node ranking method, termed Exponential Ranking (Traag et al,
2010), similar to the PageRank algorithm (Page et al, 1998). Specifi-
cally, the algorithm assigns a rank score to each node (representing
a protein) in a network (in our case a protein signaling network)
with both positively (activating) and negatively (inhibitory)
weighted links by modeling the flow of “trust” across the network
using discrete choice theory. The algorithm works by iteratively
updating the “trust” scores (in this case protein activity scores)
using the following equation:





where p is the vector of protein rank scores that will eventually
converge to estimated protein activity scores, A is the transition
matrix, and l is the sole parameter in the algorithm. In our imple-
mentation of the algorithm, we used the difference between the
maximum and minimum of the transition matrix, maxijAij–minijAij,
for parameter l, which is within the recommended range that
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guarantees convergence. To initialize the iterative procedure
outlined above, we scaled expression data predicted by the regres-
sion models to have a sum of 1 as the initial p(0) and augmented
the transition matrix using expression values of pairs of interactors,
i.e., A = xxTB where x is a column vector of expression values
and B is the weighted adjacency matrix of likelihood scores
described above. The p vector is updated using the above equa-
tion until changes between two consecutive updates (in the form
of Frobenius norm) are within a small tolerance (1 × 106). In all
downstream applications, we transformed the final protein activity
scores by taking the logarithm of all positive scores or that of the
absolute values for negative scores.
For a fair comparison with VIPER, we used the above signaling
network as the interactome, together with subtype-specific expres-
sion matrices, as input for the VIPER algorithm. We ran both expo-
nential ranking and VIPER on unperturbed expression profiles as
well as expression profiles where the expression of a (non-transcrip-
tional) regulator in known signaling pathways (e.g., EGFR) was
decreased, and compared the estimated protein activity of down-
stream signaling targets to inspect the performance of the two
models on capturing post-translational activity.
Modeling effects of gene expression perturbation in silico
To compute the effects of gene expression perturbation, in particular
that of transcription factors, we developed a recursive algorithm to
account for the hierarchical and feedback properties of transcription
regulation, i.e., the downstream targets of a perturbed TF may regu-
late another layer of TFs and/or regulate said TF itself. Since our
thermodynamics-based model of transcription regulation essential-
ity models steady-state expression levels, we use a recursive frame-
work where we traverse and update the network of transcription
regulation with a modified breadth-first search strategy that detects
feedback loops and ensures that each TF’s expression is updated
only once. A key advantage of such an algorithm is that it takes into
consideration that a target gene may also be a TF, and that a partic-
ular target gene can be regulated by multiple regulator TFs that may
also be perturbed due to a cascade of upstream perturbations. Our
algorithm is designed such that each TF can at most be perturbed
once, i.e., any given TF will not be perturbed again if it has already
been perturbed and there exists a path between that TF and its regu-
lator (i.e., a feedback loop). This ensures maximal propagation of
TF regulatory effects without creating infinite loops. The pseu-
docode for such an algorithm, implemented in the “hPerturb” func-
tion, is as follows:
function hPerturb(TFToPerturb) {
Find all targets of TFToPerturb;
if (targets of TFToPerturb contain other TFs) {
Flag the TFs within the target set that should not be
perturbed using the subroutine doNotPerturb()
outlined below;
Flag all target genes that are not in the above list and
recalculate their expression with updated TF
expression values using the nonlinear regression
model;
If there are no target TFs that are perturbed in the
previous step, return; otherwise flag these TFs as
already perturbed and recursively perturb the
downstream targets of these TFs by calling the hPerturb
() function on each of them.
} else {
Recalculate all target gene expression with updated TF
expression values using the nonlinear regression model
and return.
}
Subroutine for determining TFs that should not be perturbed:
function doNotPerturb(topmostPerturbedTF,
TFToPerturb) {
Find the target TFs which have already been perturbed
and show feedback regulation of TFToPerturb;
Find the target TFs whose regulators that reside on the
path from the topmost perturbed TF
(topmostPerturbedTF, i.e. the argument in the very
first call to the hPerturb() function) have not all
been perturbed yet;
Return the union of the above two sets.
}
Using models built from brain tumor cell line expression data in
the CCLE collection (Barretina et al, 2012), we predicted new target
gene expression profiles after simulating knockdown for each of the
518 TFs considered in our models and used the new gene expression
estimates for computing updated protein activity scores as described
in the previous section. We then built an elastic net regression
model to predict essentiality scores for each of the perturbed TFs
based on changes in protein activity upon perturbation. Specifically,
we model the TF-gene essentiality scores as determined by genetic
screens in the DepMap project (Tsherniak et al, 2017; Meyers et al,
2017) as a linear combination of changes in protein activity scores
and fitted the model using L1 and L2 regularization terms to
decrease overfitting and ensure sparsity. Hyperparameters in the
elastic net regression, i.e., strengths of L1 and L2 regularization,
were determined for each TF using 4-fold cross-validation with 80%
of available CCLE lines (for a total of 32).
To ensure that CCLE and TCGA expression profiles are comparable
and that models trained using CCLE datasets can be applied to predict-
ing gene essentiality in individual TCGA patient tumors, we performed
batch effect correction using the RemoveBatchEffects functionality in
the limma package in R (Ritchie et al, 2015). All perturbations are
performed on normalized, batch effect-corrected data.
Data availability
All code associated with the inTRINSiC pipeline and analyses in this
paper, as well as instructions on how key pipeline procedures
should be called, can be accessed from the following GitHub reposi-
tory: https://github.com/yunpengl9071/inTRINSiC.
Expanded View for this article is available online.
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